Boris Turk Selected Research

Inflammation (Inflammations)

12/2022	Cysteine cathepsins: A long and winding road towards clinics.
1/2020	Cysteine cathepsins as therapeutic targets in inflammatory diseases.
1/2019	Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment.
10/2017	The Future of Cysteine Cathepsins in Disease Management.
1/2017	Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin.
5/2015	Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.
3/2015	Detecting cathepsin activity in human osteoarthritis via activity-based probes.
1/2015	Photodynamic quenched cathepsin activity based probes for cancer detection and macrophage targeted therapy.
11/2014	A role for stefin B (cystatin B) in inflammation and endotoxemia.
3/2014	Decreased IL-10 expression in stefin B-deficient macrophages is regulated by the MAP kinase and STAT-3 signaling pathways.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boris Turk Research Topics

Disease

39	Neoplasms (Cancer) 10/2023 - 01/2002
14	Inflammation (Inflammations) 12/2022 - 08/2006
7	Breast Neoplasms (Breast Cancer) 08/2022 - 08/2015
6	Unverricht-Lundborg Syndrome (Disease, Unverricht) 11/2023 - 03/2010
6	Neoplasm Metastasis (Metastasis) 09/2019 - 05/2004
6	Rheumatoid Arthritis 01/2019 - 01/2007
6	Osteoporosis 09/2015 - 02/2004
5	Sepsis (Septicemia) 11/2023 - 11/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 12/2016
4	Carcinogenesis 02/2018 - 05/2004
3	Bone Resorption 01/2023 - 08/2014
3	Infections 01/2020 - 01/2006
3	Osteoarthritis 03/2015 - 01/2007
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 11/2023 - 02/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 08/2014
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 06/2021 - 12/2016
2	Arthritis (Polyarthritis) 01/2020 - 02/2004
2	Immune System Diseases (Immune Disorders) 01/2020 - 01/2007
2	Disease Progression 11/2019 - 06/2014
2	Melanoma (Melanoma, Malignant) 12/2018 - 05/2015
2	Pathologic Processes 03/2016 - 07/2015
2	Chagas Disease (American Trypanosomiasis) 04/2008 - 01/2006
1	Down Syndrome (Down's Syndrome) 11/2023
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 10/2023
1	Demyelinating Diseases (Demyelinating Disease) 10/2023
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 10/2023
1	Cicatrix (Scar) 01/2023
1	Animal Disease Models 01/2022
1	Seizures (Absence Seizure) 02/2021
1	Neuroinflammatory Diseases 02/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Periodontitis 01/2020
1	Salmonella Infections (Salmonellosis) 01/2020
1	Acute-Phase Reaction 12/2019
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2019
1	Necrosis 01/2019

Drug/Important Bio-Agent (IBA)

40	CathepsinsIBA 12/2022 - 01/2002
26	Cysteine (L-Cysteine)FDA Link 12/2022 - 05/2004
14	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 02/2004
14	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2005
9	Cathepsin BIBA 01/2022 - 05/2005
7	Cystatin BIBA 11/2023 - 03/2010
6	EnzymesIBA 12/2022 - 04/2005
5	Cathepsin KIBA 01/2023 - 01/2007
5	cathepsin SIBA 08/2015 - 02/2011
3	LipopolysaccharidesIBA 11/2023 - 11/2019
3	Cathepsin LIBA 10/2023 - 01/2012
3	Cysteine Proteases (Cysteine Protease)IBA 01/2023 - 09/2014
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 09/2017
3	ProteomeIBA 01/2020 - 02/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019 - 11/2014
3	CytokinesIBA 11/2014 - 09/2009
2	InflammasomesIBA 11/2023 - 12/2021
2	Peptides (Polypeptides)IBA 10/2023 - 05/2015
2	Cathepsin DIBA 10/2023 - 06/2021
2	Cystatin CIBA 12/2021 - 09/2017
2	Cathepsin CIBA 12/2020 - 04/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 08/2015
2	Fluorescent Dyes (Fluorescent Probes)IBA 09/2019 - 02/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 06/2014
2	CaspasesIBA 01/2012 - 01/2006
2	polyalanineIBA 08/2009 - 06/2009
1	Interleukin-1 (Interleukin 1)IBA 11/2023
1	pepstatin (pepstatin A)IBA 10/2023
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 10/2023
1	Sulfoglycosphingolipids (Sulfatides)IBA 10/2023
1	spinell (spinel)IBA 08/2022
1	Therapeutic UsesIBA 08/2022
1	cobalt ferriteIBA 08/2022
1	TriazolesIBA 01/2022
1	DioxinsIBA 01/2022
1	Cysteine Proteinase InhibitorsIBA 12/2021
1	Cadherins (E-Cadherin)IBA 11/2021
1	PeroxiredoxinsIBA 02/2021
1	ThioredoxinsIBA 02/2021
1	Thioredoxin-Disulfide ReductaseIBA 02/2021
1	Detergents (Detergent)IBA 12/2020
1	leucyl-leucine-methyl esterIBA 12/2020
1	IsotopesIBA 01/2020
1	MetalsIBA 01/2020
1	Gingipain Cysteine EndopeptidasesIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Leucine (L-Leucine)FDA Link 11/2019
1	NucleotidesIBA 11/2019
1	Liposomes (Liposome)IBA 11/2019
1	Cystatin AIBA 11/2019
1	Tocopherols (Tocopherol)IBA 01/2019
1	lastar AIBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	ChloridesIBA 01/2019
1	Superoxide DismutaseIBA 01/2019
1	StaurosporineIBA 01/2019
1	Vitamin K 3 (Menadione)FDA Link 01/2019

Therapy/Procedure

9	Therapeutics 10/2023 - 01/2007
2	Drug Therapy (Chemotherapy) 08/2022 - 04/2008
2	Precision Medicine 01/2017 - 01/2015
1	Transjugular Intrahepatic Portasystemic Shunt 12/2022